These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 28170421)

  • 1. Comprehensive mapping of antigen specific T cell responses in hepatitis C virus infected patients with or without spontaneous viral clearance.
    Zhang C; Hua R; Cui Y; Wang S; Yan H; Li D; Zhang Y; Tu Z; Hao P; Chen X; Zhong J; Niu J; Jin X
    PLoS One; 2017; 12(2):e0171217. PubMed ID: 28170421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
    Rutebemberwa A; Ray SC; Astemborski J; Levine J; Liu L; Dowd KA; Clute S; Wang C; Korman A; Sette A; Sidney J; Pardoll DM; Cox AL
    J Immunol; 2008 Dec; 181(12):8215-25. PubMed ID: 19050238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune selection with hepatitis C virus persistence in humans.
    Cox AL; Mosbruger T; Mao Q; Liu Z; Wang XH; Yang HC; Sidney J; Sette A; Pardoll D; Thomas DL; Ray SC
    J Exp Med; 2005 Jun; 201(11):1741-52. PubMed ID: 15939790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of antigenic variants of hepatitis C virus in immune evasion.
    Wang JH; Pianko MJ; Ke X; Herskovic A; Hershow R; Cotler SJ; Chen W; Chen ZW; Rong L
    Virol J; 2011 Jul; 8():377. PubMed ID: 21801418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal transcriptomic characterization of the immune response to acute hepatitis C virus infection in patients with spontaneous viral clearance.
    Rosenberg BR; Depla M; Freije CA; Gaucher D; Mazouz S; Boisvert M; Bédard N; Bruneau J; Rice CM; Shoukry NH
    PLoS Pathog; 2018 Sep; 14(9):e1007290. PubMed ID: 30222771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection.
    Moise L; Terry F; Gutierrez AH; Tassone R; Losikoff P; Gregory SH; Bailey-Kellogg C; Martin WD; De Groot AS
    Front Microbiol; 2014; 5():502. PubMed ID: 25339942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concerted synergy between viral-specific IgG and CD8 + T cells is critical for clearance of an HCV-related rodent hepacivirus.
    Gridley J; Holland B; Salinas E; Trivedi S; Dravid P; Elrod E; Jin F; Kumari A; Batista MN; Thapa M; Rice CM; Marcotrigiano J; Kapoor A; Grakoui A
    Hepatology; 2024 Oct; 80(4):937-950. PubMed ID: 38214558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals.
    Belperio PS; Shahoumian TA; Mole LA; Backus LI
    Hepatology; 2017 Jul; 66(1):27-36. PubMed ID: 28240789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapy for chronic hepatitis C: The role of direct-acting antivirals.
    Li G; De Clercq E
    Antiviral Res; 2017 Jun; 142():83-122. PubMed ID: 28238877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1.
    El-Diwany R; Cohen VJ; Mankowski MC; Wasilewski LN; Brady JK; Snider AE; Osburn WO; Murrell B; Ray SC; Bailey JR
    PLoS Pathog; 2017 Feb; 13(2):e1006235. PubMed ID: 28235087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo.
    Bhattarai N; McLinden JH; Xiang J; Mathahs MM; Schmidt WN; Kaufman TM; Stapleton JT
    PLoS Pathog; 2017 Feb; 13(2):e1006232. PubMed ID: 28235043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel epitope in the C terminus of hepatitis C virus-E2 protein that induces potent and cross-reactive neutralizing antibodies.
    Das S; Mullick R; Kumar A; Tandon H; Bose M; Gouthamchandra K; Chandra M; Ravishankar B; Khaja MN; Srinivasan N; Das S; Melkote Subbarao S; Karande AA
    J Gen Virol; 2017 May; 98(5):962-976. PubMed ID: 28221101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response.
    Welsch C; Efinger M; von Wagner M; Herrmann E; Zeuzem S; Welzel TM; Lange CM
    PLoS One; 2017; 12(2):e0171755. PubMed ID: 28196130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibodies against hepatitis B virus surface antigen and hepatitis C virus core antigen in plasma with a waveguide-mode sensor.
    Shimizu T; Tanaka T; Uno S; Ashiba H; Fujimaki M; Tanaka M; Awazu K; Makishima M
    J Biosci Bioeng; 2017 Jun; 123(6):760-764. PubMed ID: 28190739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study.
    Zeng QL; Xu GH; Zhang JY; Li W; Zhang DW; Li ZQ; Liang HX; Li CX; Yu ZJ
    J Hepatol; 2017 Jun; 66(6):1123-1129. PubMed ID: 28189754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants in interferon-λ 4 influences HCV clearance in Chinese Han population.
    Huang P; Yao Y; Yue M; Tian T; Chen H; Chen M; Wang J; Zhang Y; Yu R
    Sci Rep; 2017 Feb; 7():42408. PubMed ID: 28186161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
    Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China.
    Gao Y; Li Y; Liu X; Zhang T; Yu G; Wang Y; Shi Y; Chi X; Wang X; Gao X; Wu R; Zhang Y; Hang L; Sun S; Guan Y; Xu Y; Meng J; Liu X; Jiang C; Ma H; Luo L; Yan Q; Yin X; Peng F; Zhi Y; Qu W; Zhang X; Ren T; Liu L; Zhao J; Zhang F; Yakepu A; Pan Y; Xu H; Niu J
    Sci Rep; 2020 Jul; 10(1):11749. PubMed ID: 32678224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated elevated aspartate aminotransferase in an asymptomatic woman due to macro-aspartate aminotransferase: A case report.
    Zhan MR; Liu X; Zhang MY; Niu JQ
    World J Clin Cases; 2019 Dec; 7(24):4414-4419. PubMed ID: 31911926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward approval of an HCV vaccine.
    Law JL; Logan M; Landi A; Tyrrell DL; Houghton M
    Can Liver J; 2018; 1(3):130-138. PubMed ID: 35991323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.